Auto-generated from public data. Not the firm's stated position.
Based on disclosed data, 4See Ventures appears to focus on early-stage deep technology companies in life sciences, energy, and medical devices, with a particular emphasis on transformative scientific approaches. Recent portfolio suggests an investment thesis centered on pre-seed and seed-stage ventures addressing significant global challenges through novel scientific or engineering solutions, with typical check sizes in the €1.5M to €3.0M range.
Generated 10 Oct 2026 from disclosed sectors, stages, and portfolio companies. Firms can update this by emailing [email protected].
Auto-extracted from press releases.
Focus and check size from the firm's website. Website reachable as of Sept 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.